{"id":"https://openalex.org/W2186224932","doi":null,"title":"PALLIATIVE CARE PHARMACOTHERAPY LITERATURE SUMMARIES AND ANALYSES Palliative Care Pharmacotherapy Literature Summaries and Analyses","display_name":"PALLIATIVE CARE PHARMACOTHERAPY LITERATURE SUMMARIES AND ANALYSES Palliative Care Pharmacotherapy Literature Summaries and Analyses","publication_year":2007,"publication_date":"2007-01-01","ids":{"openalex":"https://openalex.org/W2186224932","mag":"2186224932"},"language":"en","primary_location":{"id":"mag:2186224932","doi":null,"is_oa":false,"landing_page_url":"https://informahealthcare.com/doi/pdf/10.1080/J354v21n01_17","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079817843","display_name":"Amy P. Abernethy","orcid":"https://orcid.org/0000-0001-6930-8722","observed_orcids":["https://orcid.org/0000-0001-6930-8722"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Amy P. Abernethy","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6930-8722","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5079817843"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10177","display_name":"Palliative Care and End-of-Life Issues","score":0.5439000129699707,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10177","display_name":"Palliative Care and End-of-Life Issues","score":0.5439000129699707,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.3732999861240387,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13340","display_name":"Palliative and Oncologic Care","score":0.04340000078082085,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/palliative-care-pharmacotherapy","display_name":"palliative care pharmacotherapy","score":0.9829999804496765},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.6159999966621399},{"id":"https://openalex.org/keywords/cox-2-inhibitors","display_name":"COX-2 inhibitors","score":0.9879999756813049},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.9879999756813049},{"id":"https://openalex.org/keywords/qt-interval-prolongation","display_name":"QT prolongation","score":0.9240000247955322},{"id":"https://openalex.org/keywords/methadone","display_name":"methadone","score":0.9750000238418579},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.8230000138282776},{"id":"https://openalex.org/keywords/scopolamine","display_name":"scopolamine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.9639999866485596},{"id":"https://openalex.org/keywords/cardiovascular-drugs","display_name":"cardiovascular drugs","score":0.890999972820282},{"id":"https://openalex.org/keywords/ethnicity","display_name":"ethnicity","score":0.8560000061988831},{"id":"https://openalex.org/keywords/medication-non-adherence","display_name":"medication non-adherence","score":0.9419999718666077},{"id":"https://openalex.org/keywords/medicare-enrollees","display_name":"Medicare enrollees","score":0.8040000200271606},{"id":"https://openalex.org/keywords/drug-costs","display_name":"drug costs","score":0.7900000214576721}],"concepts":[{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.6795216798782349},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6731142401695251},{"id":"https://openalex.org/C2994186709","wikidata":"https://www.wikidata.org/wiki/Q29483","display_name":"Palliative care","level":2,"score":0.6421951651573181},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5648276209831238},{"id":"https://openalex.org/C2993432071","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Drug reaction","level":3,"score":0.4843960404396057},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4820328950881958},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.44632455706596375},{"id":"https://openalex.org/C137403100","wikidata":"https://www.wikidata.org/wiki/Q41710","display_name":"Ethnic group","level":2,"score":0.41961729526519775},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3632572293281555},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.26491475105285645},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1860201060771942},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.16983062028884888},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.0},{"id":"https://openalex.org/C19165224","wikidata":"https://www.wikidata.org/wiki/Q23404","display_name":"Anthropology","level":1,"score":0.0},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2186224932","doi":null,"is_oa":false,"landing_page_url":"https://informahealthcare.com/doi/pdf/10.1080/J354v21n01_17","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W1971743791","https://openalex.org/W1989487766","https://openalex.org/W1991546010","https://openalex.org/W2029192447","https://openalex.org/W2061373644","https://openalex.org/W2070827451","https://openalex.org/W2077680700","https://openalex.org/W2115780912","https://openalex.org/W2159130079","https://openalex.org/W2160172135","https://openalex.org/W2166774997","https://openalex.org/W2170948133"],"related_works":["https://openalex.org/W4232915144","https://openalex.org/W1972334317","https://openalex.org/W2605042448","https://openalex.org/W4231389485","https://openalex.org/W2157341596","https://openalex.org/W4402920831","https://openalex.org/W1998363750","https://openalex.org/W4387747968","https://openalex.org/W2032922104","https://openalex.org/W1998015331"],"abstract_inverted_index":{"Timely":[0],"and":[1,6,15,44,56,61],"important":[2],"studies":[3],"are":[4],"reviewed":[5],"commentaries":[7],"provided":[8],"by":[9],"leading":[10],"palliative":[11],"care":[12],"clinicians.":[13],"Symptoms":[14],"treatment":[16,46],"side":[17],"effects":[18],"addressed":[19],"in":[20,64],"this":[21],"issue":[22],"are:":[23],"cardio-":[24],"vascular":[25],"risk":[26],"due":[27,38,67],"to":[28,39,53,68],"NSAIDs":[29],"or":[30],"COX-2":[31],"inhibitors;":[32],"prolongation":[33],"of":[34],"the":[35],"QT":[36],"interval":[37],"metha-":[40],"done":[41],"use;":[42],"depression":[43],"its":[45],"with":[47,59],"scopolamine;":[48],"adverse":[49],"drug":[50],"reactions":[51],"related":[52],"cardiovascular":[54],"medications,":[55],"their":[57],"association":[58],"ethnicity;":[60],"medication":[62],"nonadherence":[63],"Medicare":[65],"enrollees":[66],"cost":[69],"considerations.":[70],"doi:10.1300/J354v21n03_17":[71]},"counts_by_year":[],"updated_date":"2025-11-06T04:12:42.849631","created_date":"2016-06-24T00:00:00"}